Key statistics
As of last trade, N4 Pharma PLC (N4P:LSE) traded at 0.542, 54.86% above the 52 week low of 0.35 set on Jul 28, 2025.
52-week range
| Open | 0.525 |
|---|---|
| High | 0.600 |
| Low | 0.542 |
| Bid | 0.50 |
| Offer | 0.55 |
| Previous close | 0.525 |
| Average volume | 1.18m |
|---|---|
| Shares outstanding | 832.28m |
| Free float | 517.34m |
| P/E (TTM) | -- |
| Market cap | 4.37m GBP |
| EPS (TTM) | -0.0025 GBP |
Data delayed at least 20 minutes, as of Mar 05 2026 11:30 GMT.
More ▼
- Notice of GM and Proposed Change of Name
- CEO Appointment & Name Change Thalia Therapeutics
- Business and Operational Update
- Interim Results
- Partnership with University of Strathclyde’s CMAC
- N4 Pharma’s Nuvec® Targets Lung Cancer Cells
- Notice of Results, Analyst & Investor Presentation
- Investor Event and Presentation
- Article on Nuvec®’s Potential in RNA Therapeutics
- Investor Webinar
More ▼
